GGrantIndex
Sort

21,281 grants matching influenza

Chlamydial Vaccine Testing in Mice and Guinea Pigs

$533,605
Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2021 · AI

Prevention and control of Ebola virus infection

$533,515
Yoshihiro Kawaoka · University Of Chicago · U54 · FY2009 · AI

Targeting IgM Memory to Establish Protective B Cell Responses to HIV

$533,505
James J Kobie · University Of Rochester · R01 · FY2016 · AI

Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia

$533,504
Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2023 · HL

Project 1: Costimulation and Regulation of Anti-viral Immunity

$533,498
Arlene H Sharpe · Harvard Medical School · P01 · FY2016 · AI

Burkholderia pseudomallei autotransporters and TPS proteins

$533,434
David Alan Low · University Of California-Irvine · U54 · FY2013 · AI

Immunology/Influenza Virology Core

$533,275
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI

Household Studies of Influenza and Other Respiratory Viruses

$533,162
Arnold S Monto · University Of Michigan At Ann Arbor · R01 · FY2015 · AI

Core B - Clinical Core

$533,133
Rachel Margaret Presti · Washington University · U19 · FY2025 · AI

Physiology of Viral Immunity

$533,045
Jack R Bennink · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Role of innate immune responses in the activity of an Alphavirus based adjuvant.

$532,884
Robert E. Johnston · Global Vaccines, Inc. · R01 · FY2013 · AI

ELECTRONIC LABORATORY DATA EXCHANGE TO SUPPORT PANDEMIC INFLUENZA SURVEILLANCE

$532,853
Chad Smelser · New Mexico State Department Of Health · U90 · FY2008 · TP

Prenatal Determinants of Schizophrenia, II

$532,601
Catherine Ann Schaefer · Kaiser Foundation Research Institute · R01 · FY2007 · MH

Deriving correlates of protection from influenza-specific antibody and T cell receptor analysis.

$532,518
Scott Dexter Boyd · Stanford University · U19 · FY2022 · AI

USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT

$532,466
Patricia J Coon · Billings Clinic Foundation · R18 · FY2007 · DK

A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei

$532,412
Biao He · University Of Georgia · R01 · FY2020 · AI

Core D: Mouse Perturbation Core

$532,204
Arlene H Sharpe · Harvard Medical School · U19 · FY2017 · AI

Innate Control of SIV-Specific Adaptive Immunity

$532,064
Bali Pulendran · Emory University · U19 · FY2012 · AI

Structural and functional analysis of the coronavirus spike protein fusion peptide

$532,013
Gary R Whittaker · Cornell University · R01 · FY2020 · AI

Systems biological assessment of vaccination-induced protective immunity in African children

$532,012
Bali Pulendran · Stanford University · U01 · FY2024 · AI

Lethal H5N1 Virus Infection and Respiratory Disorders

$531,900
Fadi Xu · Lovelace Biomedical & Environmental Research Institute · R01 · FY2015 · HL

Patient Protection and Affordable Care Act Emerging Infections Program (EIP) Enha

$531,825
Ken A. Gershman · Colorado State Dept/Pub Hlth & Environmt · U01 · FY2010 · CI

Protein/Lipid Interactions

$531,714
Robert B. Gennis · University Of Illinois At Urbana-Champaign · R01 · FY2015 · HL

Synthetic Viral Genome Design for Rapid Vaccine Development

$531,711
Eckard Wimmer · State University New York Stony Brook · R01 · FY2008 · AI

Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity

$531,398
Yoshihiro Kawaoka · Oregon Health & Science University · U54 · FY2010 · AI